Bioprocess Capital Ventures

Investor type

VC

Founded

2006

AUM

$50 M

Location

Moscow, Moscow, Russia

Investment Ticket

$1-5 m

Investment Stage

Series B

Region of investment

Europe
Investor profile last updated: 18 August, 2026

Profile

The limited liability company Management Company Bioprocess Capital Partners was established on October 6, 2006 to manage the funds of Russian venture company (RVC). Bioprocess Capital Ventures focused on biomedical and fine chemistry startups.

Industry

Medical Devices Chemicals Biotechnology MedTech HealthTech

Contacts

Name
Title
Email
avatar
Tezov Vladimir CEO
CEO
-
avatar
Elena Kasimova Investment director
Investment director
-
Upgrade to see contacts
avatar
6jedf8IKXz9EPBrO 6jedf8IKXz9EPBrO
6jedf8IKXz9EPBrO
avatar
6jedf8IKXz9EPBrO 6jedf8IKXz9EPBrO
6jedf8IKXz9EPBrO
avatar
6jedf8IKXz9EPBrO 6jedf8IKXz9EPBrO
6jedf8IKXz9EPBrO
Investment-team contacts for Bioprocess Capital Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Bioprocess Capital Ventures

Bioprocess Capital Ventures is a venture capital firm. It backs companies at Series B, writing tickets of $1-5 m.
Bioprocess Capital Ventures is located in Moscow, Moscow, Russia.
Bioprocess Capital Ventures was founded in 2006.
Bioprocess Capital Ventures invests in companies and startups in Medical Devices, Chemicals, Biotechnology, MedTech, HealthTech.
Bioprocess Capital Ventures invests in companies and startups in Europe.
Bioprocess Capital Ventures invests in companies and startups at Series B.
Bioprocess Capital Ventures usually invests $1-5 m on average.
Bioprocess Capital Ventures has around $50m assets under management.
Bioprocess Capital Ventures can be reached through its website bcvf.ru and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Bioprocess Capital Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Bioprocess Capital Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 18 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.